Prognostic Role of TAPSE to PASP Ratio in Patients Undergoing MitraClip Procedure.
Blanca Trejo-VelascoRodrigo Estevez-LoureiroFernando Carrasco-ChinchillaFelipe Fernández-VazquezDabit ArzamendiManuel PanIsaac PascualLuis Nombela-FrancoIgnacio J Amat-SantosXavier FreixaRosa Ana Hernández-AntolínRamiro Trillo-NoucheLeire Andraka IkazuriagaJosé R López-MínguezDario Sanmiguel CerveraJuan Sanchis ForésJose Luis Diez GilValeriano Ruiz-QuevedoCristóbal Urbano-CarrilloVíctor Manuel Becerra-MuñozTomás Benito GonzálezChi Hion LiDolores MesaPablo AvanzasGermán ArmijoAna María Serrador-FrutosLaura SanchísCovadonga Fernández-Golfín LobánBelén Cid-ÁlvarezJosé María Hernández-GarcíaCarmen Garrote-ColomaEstefania Fernández-PeregrinaMiguel RomeroVíctor León ArgueroIgnacio Cruz-GonzálezPublished in: Journal of clinical medicine (2021)
TAPSE/PASP ratio appears as a novel prognostic predictor in patients undergoing MitraClip implantation that might improve risk stratification and candidate selection.